The global personal care contract manufacturing market size was valued at $21.2 billion in 2023 and is expected to grow at a CAGR of 8.5 percent from 2024 to 2030. The forecast period is anticipated to see market expansion in India as well driven by the enhancement of life quality and the ongoing consumer preference for premium and luxury cosmetic products. However, a prevalent deficiency in effective communication among players in this domain sidelines customer involvement, impeding clients’ grasp of operational intricacies and culminating in an overall degradation of product quality. At the helm of cutting-edge innovation stands Influx Healthtech, a visionary contract manufacturing firm since 2003 celebrated for its dedication to prioritize open communication and collaboration to gain a comprehensive understanding of clients’ needs.
Founded in 2003 as a small-scale operation, Influx Healthtech is set out with ambitious goals for expansion. Over the years, the firm’s dedication and determination have propelled them to the forefront of the healthcare manufacturing sector. Today, they stand as a beacon of excellence, renowned for their adherence to rigorous quality standards. With certifications including GMP, HACCP, ISO 22000 and Halal, their manufacturing facilities boast efficient manufacturing process with meticulous quality control department, and a highly skilled workforce, ensuring the production of top-tier cosmeceutical products.
“Our unwavering commitment is palpable in the relentless pursuit of innovation, consistently delivering products imbued with compelling concepts with support in delivering optimum batch sizes to customers”, says Dr. Munir Chandniwala, Managing Director.
Utmost Client Dedication
Influx Healthtech engages in comprehensive F&D or R&D endeavors for projects, meticulously ensuring the safety, reliability and noncomedogenic properties of the utilized ingredients. Their commitment extends to adherence to the FDA’s prohibited ingredient list and navigating intricate international regulations when exporting products, ensuring impeccable compliance with legal frameworks. The company operates across India and has a significant presence across four continents with a diversified client base. Their main business revolves around contract manufacturing for Nutraceuticals, Cosmetics, Herbal, Veterinary Feed Supplements and Homecare Products, offering competitive rates for various batch sizes.
Influx Healthtech’s steadfast dedication extends beyond mere product development, encompassing a strategic endeavor to cultivate and expand their customer network
Once the clients’ requirements are clarified, Influx Healthtech meticulously crafts samples to exemplify their proposed solutions, sending them to clients for review and feedback. This iterative process ensures that the final product aligns perfectly with the client’s vision before moving forward with production, fostering a strong partnership built on trust and satisfaction. Thanks to its abundant spare capacity, the firm stands well-prepared to meet delivery demands with ease. Producing between 4 to 5 tons of goods daily, their operations benefit from a well structured systems ensuring a consistent manufacturing outputs. This efficient system allows the company to maintain a competitive edge in the market by consistently delivering high-quality products on schedule.
Throughout past two decades, Influx Healthtech has journeyed through a series of noteworthy milestones, each representing a pivotal moment of achievement, while concurrently unveiling a myriad of groundbreaking products meticulously crafted to address the ever-changing needs of the market. In the foreseeable future, the enterprise is gearing up to launch an IPO. Concurrently, they have strategic plans to expand their machinery and factory operations within the next three to four years. Furthermore, the company is eyeing investments in the pet nutrition industry, foreseeing a promising future in the sector.
.jpg "Artificial Intelligence to Revolutionize Advanced Chip Design")
